Cargando…

Effectiveness of the BNT162b2 mRNA Covid-19 vaccine in Spanish healthcare workers

INTRODUCTION: Frontline health care workers (HCW) have higher risk than the general population to become infected by SARS.CoV.2, so they were a priority group for Covid-19 vaccine administration. We compared the incidence and prevalence of HCW infected pre-and post-vaccination with the BNT162b2 mRNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Núñez López, Concepción, González de Abreu, Juan Manuel, Pérez-Blanco, Verónica, de Miguel Buckley, Rosa, Romero Gómez, María Pilar, Díaz-Menéndez, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313482/
https://www.ncbi.nlm.nih.gov/pubmed/34334860
http://dx.doi.org/10.1016/j.eimc.2021.06.021
_version_ 1783729357823410176
author Núñez López, Concepción
González de Abreu, Juan Manuel
Pérez-Blanco, Verónica
de Miguel Buckley, Rosa
Romero Gómez, María Pilar
Díaz-Menéndez, Marta
author_facet Núñez López, Concepción
González de Abreu, Juan Manuel
Pérez-Blanco, Verónica
de Miguel Buckley, Rosa
Romero Gómez, María Pilar
Díaz-Menéndez, Marta
author_sort Núñez López, Concepción
collection PubMed
description INTRODUCTION: Frontline health care workers (HCW) have higher risk than the general population to become infected by SARS.CoV.2, so they were a priority group for Covid-19 vaccine administration. We compared the incidence and prevalence of HCW infected pre-and post-vaccination with the BNT162b2 mRNA COVID-19 vaccine. MATERIAL AND METHODS: Prospective observational study carried out between 01/12/20 and 07/03/21 in La Paz University Hospital, Madrid (Spain). SARS.CoV.2 positive cases in HCW after vaccination were collected and compared to those hospitalized COVID-19 patients at the same hospital. RESULTS: Two weeks after finishing the first round of vaccinations daily new cases of HCW infections (symptomatic and asymptomatic) decreased substantially and cumulative cases of infected HCW and hospitalized COVID-19 patients started to diverge. No new positive cases of HCW infection were registered seven days after the second dose of BNT162b2 mRNA COVID-19 vaccine. CONCLUSIONS: BNT162b2 mRNA COVID-19 vaccine is highly effective in Spanish HCW.
format Online
Article
Text
id pubmed-8313482
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-83134822021-07-27 Effectiveness of the BNT162b2 mRNA Covid-19 vaccine in Spanish healthcare workers Núñez López, Concepción González de Abreu, Juan Manuel Pérez-Blanco, Verónica de Miguel Buckley, Rosa Romero Gómez, María Pilar Díaz-Menéndez, Marta Enferm Infecc Microbiol Clin Original Article INTRODUCTION: Frontline health care workers (HCW) have higher risk than the general population to become infected by SARS.CoV.2, so they were a priority group for Covid-19 vaccine administration. We compared the incidence and prevalence of HCW infected pre-and post-vaccination with the BNT162b2 mRNA COVID-19 vaccine. MATERIAL AND METHODS: Prospective observational study carried out between 01/12/20 and 07/03/21 in La Paz University Hospital, Madrid (Spain). SARS.CoV.2 positive cases in HCW after vaccination were collected and compared to those hospitalized COVID-19 patients at the same hospital. RESULTS: Two weeks after finishing the first round of vaccinations daily new cases of HCW infections (symptomatic and asymptomatic) decreased substantially and cumulative cases of infected HCW and hospitalized COVID-19 patients started to diverge. No new positive cases of HCW infection were registered seven days after the second dose of BNT162b2 mRNA COVID-19 vaccine. CONCLUSIONS: BNT162b2 mRNA COVID-19 vaccine is highly effective in Spanish HCW. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. 2023-01 2021-07-27 /pmc/articles/PMC8313482/ /pubmed/34334860 http://dx.doi.org/10.1016/j.eimc.2021.06.021 Text en © 2021 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Núñez López, Concepción
González de Abreu, Juan Manuel
Pérez-Blanco, Verónica
de Miguel Buckley, Rosa
Romero Gómez, María Pilar
Díaz-Menéndez, Marta
Effectiveness of the BNT162b2 mRNA Covid-19 vaccine in Spanish healthcare workers
title Effectiveness of the BNT162b2 mRNA Covid-19 vaccine in Spanish healthcare workers
title_full Effectiveness of the BNT162b2 mRNA Covid-19 vaccine in Spanish healthcare workers
title_fullStr Effectiveness of the BNT162b2 mRNA Covid-19 vaccine in Spanish healthcare workers
title_full_unstemmed Effectiveness of the BNT162b2 mRNA Covid-19 vaccine in Spanish healthcare workers
title_short Effectiveness of the BNT162b2 mRNA Covid-19 vaccine in Spanish healthcare workers
title_sort effectiveness of the bnt162b2 mrna covid-19 vaccine in spanish healthcare workers
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313482/
https://www.ncbi.nlm.nih.gov/pubmed/34334860
http://dx.doi.org/10.1016/j.eimc.2021.06.021
work_keys_str_mv AT nunezlopezconcepcion effectivenessofthebnt162b2mrnacovid19vaccineinspanishhealthcareworkers
AT gonzalezdeabreujuanmanuel effectivenessofthebnt162b2mrnacovid19vaccineinspanishhealthcareworkers
AT perezblancoveronica effectivenessofthebnt162b2mrnacovid19vaccineinspanishhealthcareworkers
AT demiguelbuckleyrosa effectivenessofthebnt162b2mrnacovid19vaccineinspanishhealthcareworkers
AT romerogomezmariapilar effectivenessofthebnt162b2mrnacovid19vaccineinspanishhealthcareworkers
AT diazmenendezmarta effectivenessofthebnt162b2mrnacovid19vaccineinspanishhealthcareworkers
AT effectivenessofthebnt162b2mrnacovid19vaccineinspanishhealthcareworkers
AT effectivenessofthebnt162b2mrnacovid19vaccineinspanishhealthcareworkers